Literature DB >> 3467979

Effects of intracamerally infused prostaglandins on outflow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle.

P L Kaufman.   

Abstract

Cynomolgus monkeys with intact or surgically retrodisplaced ciliary muscle received intracameral infusion of prostaglandins (PG) E1, E2, and F2 alpha in doses yielding initial anterior chamber concentrations ranging from approximately 0.2 microM to approximately 0.2 mM. The effects on total outflow facility, as determined by two-level constant pressure perfusion, within the first 40 min after PG infusion were at most sporadic and minimal, and PGF2 alpha had no effect at any of the dosages given. Thus, these autacoids seem to exert little if any acute functional effect on the conventional outflow routes in this primate species when administered intracamerally under these experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3467979     DOI: 10.1016/s0014-4835(86)80012-4

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

Review 1.  Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2007-10-26       Impact factor: 3.467

2.  Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma.

Authors:  J Villumsen; A Alm; M Söderström
Journal:  Br J Ophthalmol       Date:  1989-12       Impact factor: 4.638

3.  Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.

Authors:  J Villumsen; A Alm
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

4.  The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.

Authors:  Sven Dinslage; Arno Hueber; Michael Diestelhorst; Günther Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.